πŸ‡ΊπŸ‡Έ FDA
Patent

US 9108903

Amides as modulators of sodium channels

granted A61KA61K31/192A61K31/44

Quick answer

US patent 9108903 (Amides as modulators of sodium channels) held by Vertex Pharmaceuticals Incorporated expires Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Aug 18 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 13 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/192, A61K31/44, A61P, A61P13/00